ABT-737 is a potent BH3 mimetic small-molecule inhibitor that functions by binding with high affinity to Bcl-2 and Bcl-xL proteins. By preventing these proteins from sequestering proapoptotic molecules,… Read more
ABT-737 is a potent BH3 mimetic small-molecule inhibitor that functions by binding with high affinity to Bcl-2 and Bcl-xL proteins. By preventing these proteins from sequestering proapoptotic molecules, this compound effectively shifts the balance of cell survival pathways to induce apoptosis, making it a critical tool in oncology research for evaluating new cancer therapies. Laboratories utilize the reference standards, impurities, and metabolites found in this category to support rigorous analytical testing and method validation. Stable isotope labelled compounds, such as deuterated analogs, are particularly essential in pharmaceutical research for serving as internal standards in mass spectrometry. These high-quality reference materials ensure precise impurity profiling and accurate quantification, which are vital for maintaining stringent quality control and achieving regulatory compliance throughout the drug development process.